logo
How to use AI to write your résumé

How to use AI to write your résumé

Fast Company9 hours ago

Love or hate AI, it's reshaping how we apply to jobs. While nearly a third of job candidates think AI is hurting their job search, according to recent research from Career Group Companies, the same report found 62% of candidates using AI to write a résumé, cover letter, or writing sample for a job application—up from 32% just six months ago.
So if you can't beat 'em, how do you join them and use AI to write résumés that stand out in a sea of applications? Résumé writing experts say it's important to avoid common pitfalls and know when a human touch is irreplaceable.
Where AI shines
The most common resume mistakes job seekers make is overlooking the fact that they need to make a good impression on hiring managers who are strangers, Marc Cenedella, founding CEO of Ladders, a résumé and career services company, pointed out. Résumés need to be clearly formatted and free from errors to help these strangers focus their attention on getting to know a candidate, what they've already done, and what they could do in a new role.
AI can help with the 'common, silly errors that end up hurting [candidates] in the job search,' Cenedella said. Some of these errors can be fixed by simply asking AI to reformat or proofread a résumé. AI programs can also help change the tone or word choices in a résumé to match what a certain company is looking for.
For people looking to switch jobs or enter a new field, AI can also make a good career coach, said Dana Leavy-Detrick, founder of Brooklyn Resume Studio. It can help brainstorm new roles that fit a candidate's existing skill set, and it can analyze job postings to anticipate how a candidate's résumé will stack up against the competition.
AI can make it easier than ever to create a polished résumé. But with so many candidates using AI, résumé experts emphasize that human insight is still necessary for crafting a résumé that will stand out to hiring managers.
'What I've noticed is that the floor of resumes has gone up,' said Keith Wolf, cofounder and CEO of ResumeSpice, a résumé consultation service. He pointed out hiring managers are seeing more 'okay' résumés, those he'd rate a 5/10. 'It's really easy to go from a zero or two to a five [due to AI], but there are so many fives,' he said
Taking your résumé to the next level requires understanding how to differentiate yourself with a human touch.
Where human insight matters
Although AI is evolving rapidly it still can't communicate the full experience of a candidate the way a human-written résumé can. 'There are always nuances about your field and about the way humans talk about experiences that AI doesn't quite pick up on,' Cenedella said.
Using words that accurately describe a previous role—rather than just the words AI might come up with—helps lend credibility to a job seeker's application. This concern about credibility and authenticity is particularly relevant given that as many as 10% of job seekers admit to having lied on their résumé, often using AI tools like Open AI's ChatGPT to do so, according to a recent survey from AI Resume Builder of nearly eight thousand U.S. adults.
'It's pretty easy to spot when somebody's used AI to just throw in a bunch of keywords and terminology that doesn't really relate to what we know somebody at that level would be doing,' Cenedella said.
Beyond capturing the nuance and correct terminology used in a job seeker's field, AI may also struggle to keep up with changes in hiring processes. Recruiters' preferences about résumé formatting and the types of applicant tracking systems they use are always changing, Wolf said, so it's important to customize a résumé before sending it out—even when using AI.
How to leverage AI
For job seekers who want to use AI in their résumé writing process, résumé experts say it's important not to expect its first attempt to be a perfect fit for the job you are applying to. Because AI relies on aggregating initial information, 'at best, you're sounding like what's already out there,' Leavy-Detrick said.
One way to avoid writing a generic résumé, Cenedella suggests, is to ask the AI program to answer questions—such as, What are 10 pieces of advice for improving this résumé?—from the standpoint of a recruiter. By asking the program to act as a recruiter in their field, job seekers can get more targeted suggestions.
Another key piece of advice, Cenedella said, is to ask AI to help candidates quantify the impact they had in previous roles. 'Every job in every field on planet Earth in 2025 can be described in numbers,' Cenedella added. Adding those numbers is an effective way to help recruiters understand a job seeker's potential, and AI programs can suggest ways to seamlessly add these numbers into the résumé.
Above all, the résumé experts suggested staying true to your own story and experiences throughout the job search, rather than letting AI take the reins.
'At the end of the day, what you're doing is getting a story across,' Leavy-Detrick says. 'You want to put your own voice on it. Trust your own voice, because [AI] can't tell that story for you.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

How Much the Average Middle-Class American Has Gained in the Stock Market Since Trump Announced His Tariffs
How Much the Average Middle-Class American Has Gained in the Stock Market Since Trump Announced His Tariffs

Yahoo

time16 minutes ago

  • Yahoo

How Much the Average Middle-Class American Has Gained in the Stock Market Since Trump Announced His Tariffs

According to Gallup, 71% of middle-income Americans are invested in the stock market, and they've watched their fortunes rise and fall repeatedly during the volatile period since President Donald Trump announced his trade tariffs on April 2. But as the official start of summer approaches, those who resisted the urge to panic-sell during the frightening declines have largely seen their discipline pay off. Check Out: Read Next: It's impossible to gauge what the average middle-class investor might have gained or lost because the concept is a construct, regardless of the investor's socioeconomic class. Even if it were possible to put a dollar amount on the mean middle-class earner's stock investments, that would ignore critical variables like that investor's: Type, size and number of stock or fund holdings Portfolio makeup Portfolio diversity Degree of leverage from options trading or margin borrowing Trade frequency Fees and expenses Discover More: For context on just how differently two otherwise similar middle-class investors can perform, consider that Warner Bros Discovery Inc. (WBD) cratered on April 2 and retained a 24% overall loss through June 10. Conversely, Palantir Technologies Inc. (PLTR) has been one of the top performers in the post-tariff era, adding most of its 74% year-to-date gains since April 2. Two middle-class stock pickers with identical incomes and backgrounds who rolled the anti-diversification dice by purchasing identical amounts in either stock on April 1 would have had radically different outcomes between then and mid-June. A more reliable metric might be the major indices that so many middle-class households invest in through their 401(k)s, IRAs, index funds and ETFs. Between April 2 and June 10: The S&P 500, the benchmark index for the U.S. stock market, gained 6.16%. The Dow Jones Industrial Average, which tracks the blue chips, gained 1.31%. The tech-heavy and more volatile Nasdaq gained 11.57%. The FTSE All Cap Index, which includes much of the global stock market with 10,000 small-, mid- and large-cap companies in both developed and emerging markets, gained 7.22%. The average among all four is 6.57%, which is roughly what typical middle-class earners might have gained since April 2 if they followed the conventional advice of diversifying their portfolios with a blend of blue chips, growth stocks and foreign equities, and holding their positions regardless of market behavior. More From GOBankingRates 3 Luxury SUVs That Will Have Massive Price Drops in Summer 2025 Clever Ways To Save Money That Actually Work in 2025 7 Tax Loopholes the Rich Use To Pay Less and Build More Wealth This article originally appeared on How Much the Average Middle-Class American Has Gained in the Stock Market Since Trump Announced His Tariffs

NHS faces paying more for US drugs to avoid future Trump tariffs
NHS faces paying more for US drugs to avoid future Trump tariffs

Yahoo

time30 minutes ago

  • Yahoo

NHS faces paying more for US drugs to avoid future Trump tariffs

Britain faces paying more for US drugs as part of a deal to avoid future tariffs from Donald Trump. The NHS will review drug pricing to take into account the 'concerns of the president', according to documents released after a trade agreement was signed earlier this year. White House sources said it expected the NHS to pay higher prices for American drugs in an attempt to boost the interests of corporate America. A Westminster source said: 'There's an understanding that we would look at the drug pricing issue in the concerns of the president.' The disclosure is likely to increase concerns about American interference in the British health service, which has long been regarded as a flashpoint in trade talks. It comes after Rachel Reeves announced a record £29 billion investment in the NHS in last week's spending review. The Chancellor's plans will drive spending on the health service up towards 50 per cent of all taxpayer expenditure by the mid-2030s, according to economists at the Resolution Foundation. The Telegraph has also learnt that under the terms of the trade deal with America, the UK has agreed to take fewer Chinese drugs, in a clause similar to the 'veto' given to Mr Trump over Chinese investment in Britain. The White House has asked the UK for assurances that steel and pharmaceutical products exported to the US do not originate in China, amid fears the deal could be used to 'circumvent' Mr Trump's punishing tariffs on Beijing. Mr Trump is enraged by how much more America pays for drugs compared with other countries and considers it to be the same issue as he has raised on defence spending. Just as the US president has heaped pressure on European nations to increase the GDP share they allocate to defence, he thinks they should spend more on drug development. An industry source said: 'The way we've been thinking about it and many in the administration have been thinking about it, it's more like the model in Nato, where countries contribute some share of their GDP.' Britain and the US 'intend to promptly negotiate significantly preferential treatment outcomes on pharmaceuticals and pharmaceutical ingredients', the trade deal reads. Pharmaceutical companies are also pushing for reductions in the revenue sales rebates they pay to the NHS under the voluntary scheme for branded medicines pricing, access and growth (VPAG) – a mechanism that the UK uses to make sure the NHS does not overpay. Last week, Albert Bourla, Pfizer's chief executive, said non-US countries were 'free-riding' and called for a US government-led push to make other nations increase their proportionate spend on innovative medicines. He said White House officials were discussing drug prices in trade negotiations with other countries. 'We represent in UK 0.3pc of their GDP per capita. That's how much they spend on medicine. So yes, they can increase prices,' Mr Bourla said. Industry sources said there was no indication yet on what the White House would consider to be a fair level of spending. Whatever the benchmark, Britain will face one of the biggest step-ups. UK expenditure on new innovative medicines is just 0.28pc of its GDP, roughly a third of America's proportionate spending of 0.78pc of its GDP. Even among other G7 nations, the UK is an anomaly. Germany spends 0.4pc of its GDP while Italy spends 0.5pc. Most large pharmaceutical companies generate between half and three quarters of their profits in the US, despite the fact that America typically makes up less than a fifth of their sales. This is because drug prices outside of the US can cost as little as 30pc of what Americans pay. Yet, pharmaceutical companies rely on higher US prices to fund drug research and development, which the rest of the world benefits from. A month ago, Mr Trump signed an executive order titled 'Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients', which hit out at 'global freeloading' on drug pricing. It stated that 'Americans should not be forced to subsidise low-cost prescription drugs and biologics in other developed countries, and face overcharges for the same products in the United States' and ordered his commerce secretary to 'consider all necessary action regarding the export of pharmaceutical drugs or precursor material that may be fuelling the global price discrimination'. Trung Huynh, the head of pharma analysis at UBS, said: 'The crux of this issue is Trump thinks that the US is subsidising the rest of the world with drug prices. 'The president has said he wants to equalise pricing between the US and ex-US. And the way he wants to do it is not necessarily to bring down US prices all the way to where ex-US prices are, but he wants to use trade and tariffs as a pressure point to get countries to increase their prices. 'If he can offset some of the price by increasing prices higher ex-US, then the prices in America don't have to go down so much.' Mr Huynh added: 'It's going to be very hard for him to do. Because [in the UK deal] it hinges on the NHS, which we know has got zero money.' Under VPAG, pharmaceutical companies hand back at least 23pc of their revenue from sales of branded medicines back to the NHS, worth £3bn in the past financial year. The industry is pushing for this clawback to be cut to 10pc, which would mean the NHS would have to spend around 1.54bn more on the same medicines on an annual basis. The Government has already committed to reviewing the scheme, a decision which is understood to pre-date US trade negotiations. A government spokesman said: 'This Government is clear that we will only ever sign trade agreements that align with the UK's national interests and to suggest otherwise would be misleading. 'The UK has well-established and effective mechanisms for managing the costs of medicines and has clear processes in place to mitigate risks to supply.'

TeamDesk Integration with OpenAI- A Guide to Unlocking AI-Powered Efficiency
TeamDesk Integration with OpenAI- A Guide to Unlocking AI-Powered Efficiency

Time Business News

time30 minutes ago

  • Time Business News

TeamDesk Integration with OpenAI- A Guide to Unlocking AI-Powered Efficiency

In today's fast-paced digital world, businesses are constantly looking for ways to optimize workflows and improve decision-making. TeamDesk, a powerful online database system, enables businesses to organize and manage data effectively. However, integrating TeamDesk with OpenAI can take data management to a whole new level by introducing AI-powered automation, insights, and intelligent decision-making. This article explores the benefits of integrating TeamDesk with OpenAI, potential use cases, and step-by-step instructions on how to set up this integration for enhanced business performance. Benefits of Integrating TeamDesk with OpenAI By linking TeamDesk with OpenAI, businesses can unlock numerous advantages, such as: Automated Data Processing: AI models can analyze vast amounts of data stored in TeamDesk, extract insights, and generate reports automatically. Natural Language Processing (NLP): OpenAI's NLP capabilities allow businesses to interpret unstructured text data, classify customer queries, and provide sentiment analysis. Enhanced Customer Support: AI-powered chatbots can interact with customers using data stored in TeamDesk, ensuring accurate and contextual responses. Predictive Analytics: Businesses can forecast trends, customer behaviors, and sales patterns using OpenAI's predictive capabilities. Document Generation: AI can generate contracts, reports, and summaries based on data from TeamDesk. Task Automation: AI-driven automation reduces manual effort in processing and updating records within TeamDesk. Use Cases for TeamDesk and OpenAI Integration 1. AI-Powered Data Analysis Organizations can use OpenAI to analyze large datasets stored in TeamDesk and derive meaningful insights. For example, an HR department can process employee feedback and extract key sentiment trends. 2. Automated Report Generation Instead of manually compiling reports, OpenAI can generate executive summaries, sales reports, and performance evaluations based on structured data from TeamDesk. 3. Customer Support Automation Integrating OpenAI with TeamDesk allows businesses to deploy AI chatbots that fetch real-time data from the database, offering customers accurate and quick responses. 4. Email Automation OpenAI can draft and personalize email responses based on customer interactions stored in TeamDesk, ensuring better engagement and efficiency. 5. Fraud Detection & Risk Management With AI's pattern recognition capabilities, businesses can identify unusual activities and flag potential fraudulent transactions in their database. Steps to Integrate TeamDesk with OpenAI To successfully integrate TeamDesk with OpenAI, follow these steps: Step 1: Set Up API Access for TeamDesk TeamDesk provides API access to interact with external applications. To enable API access: Log into TeamDesk. Navigate to Setup > Integrations > API Access. Generate an API key to allow external applications (such as OpenAI) to interact with TeamDesk. Note down the API endpoint for retrieving and updating records. Step 2: Obtain OpenAI API Key To use OpenAI's capabilities: Visit OpenAI's website and sign up for an API key. Choose the AI model you want to use (GPT-4, GPT-3.5, or fine-tuned models). Save the API key securely for later use. Step 3: Connect TeamDesk and OpenAI Using a Middleware Since TeamDesk and OpenAI use different APIs, middleware such as Zapier, Make (formerly Integromat), or custom scripts can help connect them. Using Zapier: Create a Zap and select TeamDesk as the trigger. Choose an event (e.g., 'New Record Created' or 'Updated Record'). Select OpenAI as the action app and define the task (e.g., 'Summarize Text' or 'Generate Email Response'). Map the fields between TeamDesk and OpenAI. Activate the Zap to automate the workflow. Step 4: Develop a Custom Integration (Optional) For more control, businesses can develop a custom integration using Python or JavaScript. Example: Python Script for TeamDesk & OpenAI Integration import requests def get_teamdesk_data(): teamdesk_url = ' headers = {'Authorization': 'Bearer YOUR_TEAMDESK_API_KEY'} response = headers=headers) return def send_to_openai(prompt): openai_url = ' headers = {'Authorization': 'Bearer YOUR_OPENAI_API_KEY', 'Content-Type': 'application/json'} data = {'model': 'gpt-4', 'prompt': prompt, 'max_tokens': 200} response = headers=headers, json=data) return data = get_teamdesk_data() prompt = 'Summarize this customer feedback: ' + str(data) result = send_to_openai(prompt) print(result['choices'][0]['text']) Step 5: Test and Deploy After setting up the integration: Test the workflow to ensure seamless data transfer. Optimize the AI model's responses for accuracy. Deploy the integration and monitor performance. Conclusion Integrating TeamDesk with OpenAI enables businesses to leverage AI for automating workflows, enhancing customer service, and driving data-driven decision-making. Whether through no-code platforms like Zapier or custom-built Python scripts, this integration can transform business operations. By combining the power of structured databases with AI-driven insights, organizations can boost efficiency, reduce manual tasks, and enhance productivity. Ready to take your data management to the next level? Start integrating TeamDesk with OpenAI today! TIME BUSINESS NEWS

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store